Back to results
US 2026/0077056 A1Published application
Linker-payload compound, conjugates and applications thereof
AssigneesGenequantum Healthcare (Suzhou) Co., Ltd., Genequantum Medicine (Suzhou) Co., Ltd.
InventorsGang QIN, Zhaoxiong CAI, Mingyu HU
Life of this patent
Estimating the term…
Abstract
A linker-payload compound for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof are provided.
Claims19
A compound having the structure of formula (II)
- wherein,
- Q is hydrogen or LKb-P;
- M is hydrogen or LKa-LKb-P;
- provided that Q and M are not simultaneously hydrogen;
- each LKa is independently selected from
- opSu is
- or a mixture thereof;
- each LKb is independently L2-L1;
- P is a payload which is linked to the L1 moiety;
- L1 is Cleavable sequence 1 comprising an amino acid sequence which can be cleaved by enzyme, and Cleavable sequence 1 comprises 1-10 amino acids;
- L2 is a bond;
- or a C2-20 alkylene wherein one or more —CH2— structures in the alkylene is optionally replaced by —CR1R2—, —O—, —(CO)—, —S(═O)2—, —NR3—, —N⊕R4R5—, C4-10 cycloalkylene, C4-10 heterocyclylene, phenylene;
- wherein the cycloalkylene, heterocyclylene and phenylene are each independently unsubstituted or substituted with at least one substituent selected from halogen, —C1-10 alkyl, —C1-10 haloalkyl, —C1-10 alkylene-NH—R6 and —C1-10 alkylene-O—R7;
- Ld2 and each Ld1 are independently a bond;
- or selected from —NH—C1-20 alkylene-(CO)—, —NH—(PEG);
- —(CO)—, or is a natural amino acid or oligomeric natural amino acids having a degree of polymerization of 2-10 independently unsubstituted or substituted with -(PEG)j-R8 on the side chain;
- -(PEG)i- and -(PEG)j- are each a PEG fragment, which comprises the denoted number of consecutive —(O—C2H4)— structure units or consecutive —(C2H4—O)— structure units, with an optional additional C1-10 alkylene at one terminal;
- R1, R2, R3, R4, R5, R6, R7 are each independently selected from hydrogen, halogen, —C1-10 alkyl, —C1-10 haloalkyl, C4-10 cycloalkylene;
- R8 is C1-10 alkyl;
- n is any integer of 2 to 20;
- d is 0, or is any integer of 1 to 6;
- each i is independently an integer of 1-100, preferably 1 to 20;
- preferably each i is independently an integer of 1 to 12;
- more preferably 2 to 8;
- particularly 4;
- each j is independently an integer of 1-100, preferably 1 to 20;
- preferably each j is independently an integer of 1 to 12;
- more preferably 8 to 12;
- particularly 8 or 12.
26 more elements
A conjugate having the structure of formula (III):
- wherein,
- Q is hydrogen or LKb-P;
- M is hydrogen or LKa-LKb-P;
- provided that Q and M are not simultaneously hydrogen;
- A is a targeting molecule which is linked to the Gn moiety of the compound of formula (II);
- G is glycine;
- z is an integer of 1 to 20;
- each LKa is independently selected from
- opSu is
- or a mixture thereof;
- each LKb is independently L2-L1;
- P is a payload which is linked to the L1 moiety;
- L1 is Cleavable sequence 1 comprising an amino acid sequence which can be cleaved by enzyme, and Cleavable sequence 1 comprises 1-10 amino acids;
- L2 is a bond;
- or a C2-20 alkylene wherein one or more —CH2— structures in the alkylene is optionally replaced by —CR1R2—, —O—, —(CO)—, —S(═O)2—, —NR3, —N⊕R4R5, C4-10 cycloalkylene, C4-10 heterocyclylene, phenylene;
- wherein the cycloalkylene, heterocyclylene and phenylene are each independently unsubstituted or substituted with at least one substituent selected from halogen, —C1-10 alkyl, —C1-10 haloalkyl, —C1-10 alkylene-NH—R6 and —C1-10 alkylene-O—R7;
- Ld2 and each Ld1 are independently a bond;
- or selected from —NH—C1-20 alkylene-(CO)—, —NH—(PEG);
- —(CO)—, or is a natural amino acid or oligomeric natural amino acids having a degree of polymerization of 2-10 independently unsubstituted or substituted with -(PEG)j-R8 on the side chain;
- -(PEG)i- and —(PEG)j- are each a PEG fragment, which comprises the denoted number of consecutive —(O—C2H4)— structure units or consecutive —(C2H4—O)— structure units, with an optional additional C1-10 alkylene at one terminal;
- R1, R2, R3, R4, R5, R6, R7 are each independently selected from hydrogen, halogen, —C1-10 alkyl, —C1-10 haloalkyl, C4-10 cycloalkylene;
- R8 is C1-10 alkyl;
- n is any integer of 2 to 20;
- d is 0, or is any integer of 1 to 6;
- each i is independently an integer of 1-100, preferably 1 to 20;
- preferably each i is independently an integer of 1 to 12;
- more preferably 2 to 8;
- particularly 4;
- each j is independently an integer of 1-100, preferably 1 to 20;
- preferably each j is independently an integer of 1 to 12;
- more preferably 8 to 12;
- particularly 8 or 12.
29 more elements
Dependencies are inferred from the claim text.